Comparison of vitamin D hydroxylation activities of rat CYP2J3 and human CYP2J2

被引:0
|
作者
Ohyama, Y [1 ]
Aiba, I [1 ]
Yamasaki, T [1 ]
Terato, H [1 ]
Ide, H [1 ]
机构
[1] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Japan
来源
Proceedings of the 14th International Conference on Cytochromes P450: Biochemistry, Biophysics, and Bioinformatics | 2005年
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant rat CYP2J3 and human CYP2J2 were successfully expressed in the E. coli expression system by co-expression of chaperone proteins. Purified proteins were applied to analysis of catalytic activities toward vitamin D compounds using a reconstituting system containing NADPH-P450 reductase. The CYP2J2 showed significant but about 10 times lower 25-hydroxylation activities than CYP2J3 toward vitamin D-3 and 1 alpha-OH-D-3. Interestingly, CYP2J2 prefers vitamin D-2 to vitamin D-3 as a substrate, whereas CYP2J3 did vitamin D-3 to vitamin D-2, The results suggest involvement of CYP2J subfamily proteins in vitamin D activation through 25-hydroxylation reaction, although they showed distinct preferences and activities toward vitamin D compounds.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [21] INTERSUBJECT VARIABILITY CYP2J2 ACTIVITY IN HUMAN HEART MICROSOMES.
    Huguet, J.
    Gaudette, F.
    Belanger, F.
    Michaud, V.
    Turgeon, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S30 - S30
  • [22] CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes
    Eric A. Evangelista
    Theresa Aliwarga
    Nona Sotoodehnia
    Paul N. Jensen
    Barbara McKnight
    Rozenn N. Lemaitre
    Rheem A. Totah
    Sina A. Gharib
    Scientific Reports, 10
  • [23] Computational modelling of the binding of arachidonic acid to the human monooxygenase CYP2J2
    Proietti, G.
    Abelak, K. K.
    Bishop-Bailey, D.
    Macchiarulo, A.
    Nobeli, I.
    JOURNAL OF MOLECULAR MODELING, 2016, 22 (11)
  • [24] Computational modelling of the binding of arachidonic acid to the human monooxygenase CYP2J2
    G. Proietti
    K. K. Abelak
    D. Bishop-Bailey
    A. Macchiarulo
    I. Nobeli
    Journal of Molecular Modeling, 2016, 22
  • [25] CYP2J2基因的研究进展
    王莉
    王永芹
    青海医药杂志, 2018, 48 (08) : 74 - 76
  • [26] Analysis of CYP2J2 mutations in the Chinese Uyghur population
    Li, Haiyue
    He, Yongjun
    Wang, Li
    Xing, Shishi
    Peng, Linna
    Yuan, Dongya
    Jin, Tianbo
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10871 - 10881
  • [27] Association of CYP2J2 gene polymorphisms with ischemic stroke
    Li, Qing
    Zhao, Jian-Hua
    Ma, Peng-Ju
    Su, Lin-Lin
    Tao, Sheng-Bo
    Ji, Si-Bei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8163 - 8167
  • [28] Potency and mechanism of CYP2J2 inhibition by major phytocannabinoids
    Yamaori, Satoshi
    Nagata, Yousuke
    Ohmori, Shigeru
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    DRUG METABOLISM REVIEWS, 2016, 48 : 89 - 89
  • [29] Cloning of CYP2J2 gene and identification of functional polymorphisms
    King, LM
    Ma, JX
    Srettabunjong, S
    Graves, J
    Bradbury, JA
    Li, LP
    Spiecker, M
    Liao, JK
    Mohrenweiser, H
    Zeldin, DC
    MOLECULAR PHARMACOLOGY, 2002, 61 (04) : 840 - 852
  • [30] Ophiopogonin D Increases SERCA2a Interaction with Phospholamban by Promoting CYP2J3 Upregulation
    Wang, Jia
    You, Wenting
    Wang, Ningning
    Zhou, Wei
    Ge, Yunxuan
    Ma, Zengchun
    Tan, Hongling
    Wang, Yuguang
    Gao, Yue
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020